ABCL

Abcellera Biologics Inc.

• Simply Wall St·05/24 11:15

  AbCellera Biologics (ABCL) Valuation Check After ABCL635 Phase 1 Update And Improved Quarterly Results

• TipRanks·05/22 11:40

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), AbCellera Biologics (ABCL) and Indivior (INDV)

• TipRanks·05/20 12:45

  Largest borrow rate increases among liquid names

• PUBT·05/19 18:01

  AbCellera publishes corporate overview on internal antibody pipeline, platform expansion strategy

• TipRanks·05/19 02:12

  AbCellera Insider Makes Bold Move With Fresh Share Purchase

• Simply Wall St·05/19 01:30

  Is AbCellera (ABCL) Quietly Rewriting Its Business Model With ABCL635’s Phase II Menopause Bet?

• PUBT·05/18 16:10

  AbCellera director John S. Montalbano acquires 20,000 common shares for $95,400

• Simply Wall St·05/16 20:22

  A Look At AbCellera Biologics (ABCL) Valuation As ABCL-635 Advances Into Phase II Trials

• Simply Wall St·05/14 12:50

  Earnings Update: Here's Why Analysts Just Lifted Their AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target To US$10.14

• Simply Wall St·05/13 00:55

  AbCellera Biologics (ABCL) Q4 Revenue Surge Tests High 20.1x P/S Growth Narrative

• TipRanks·05/13 00:11

  AbCellera Biologics Bets Big on 2026 Trial Catalysts

• TipRanks·05/12 14:25

  Evan Seigerman Reiterates Buy on AbCellera, Citing Strong ABCL635 Phase 1 Data and Platform Strength; $7 Price Target Maintained

• TipRanks·05/12 13:21

  Analysts Offer Insights on Healthcare Companies: Phreesia (PHR), AbCellera Biologics (ABCL) and PACS Group Inc (PACS)

• TipRanks·05/12 11:40

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: West Pharmaceutical Services (WST), CVRx (CVRX) and AbCellera Biologics (ABCL)

• TipRanks·05/12 10:58

  AbCellera price target raised to $8 from $7 at Stifel